Abstract
Inherited cardiomyopathies, including hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM), are the most common monogenic cause of cardiac disease and can rarely lead to sudden cardiac death (SCD). They are characterized by incomplete and age-dependent penetrance and are usually initially symptomatic in adulthood yet can present in childhood as well. Over 20 genes have been identified to cause HCM, and more than 40 genes are known to cause DCM. Genetic testing for these genes has been integrated into medical care; however, the psychological impact of genetic testing and the impact of the uncertainty that comes with receiving these results have not been well studied. This study surveyed 90 adult probands and relatives with a personal or family history of cardiomyopathy from a single hospital-based cardiac genetic program to determine the psychosocial impact of genetic testing for cardiomyopathies. Standardized psychological instruments including an adapted Multidimensional Impact of Cancer Risk Assessment (aMICRA), Impact of Event Scale (IES), and Satisfaction with Decision (SWD) scales were utilized. Patients with positive genetic test results had higher scores for intrusive thoughts, avoidance, and distress when compared to those with negative genetic test results and were also more likely to make or plan to make life changes because of the results of their genetic testing. Satisfaction with the decision to undergo genetic testing was similar regardless of genetic test results. The results of this study provide insight into the patient experience of genetic testing for cardiomyopathies and how these experiences are associated with genetic test results and cardiac history.
Similar content being viewed by others
References
Ackerman, M. J., Priori, S. G., Willems, S., Berul, C., Brugada, R., Calkins, H., et al. (2011). HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm, 8(8), 1308–1339. https://doi.org/10.1016/j.hrthm.2011.05.020.
Beran, T. M., Stanton, A. L., Kwan, L., Seldon, J., Bower, J. E., Vodermaier, A., & Ganz, P. A. (2008). The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal? Annals of Behavioral Medicine, 36(2), 107–116. https://doi.org/10.1007/s12160-008-9060-9.
Burke, M. A., Cook, S. A., Seidman, J. G., & Seidman, C. E. (2016). Clinical and mechanistic insights into the genetics of cardiomyopathy. Journal of the American College of Cardiology, 68(25), 2871–2886. https://doi.org/10.1016/j.jacc.2016.08.079.
Burns, C., Yeates, L., Spinks, C., Semsarian, C., & Ingles, J. (2017). Attitudes, knowledge and consequences of uncertain genetic findings in hypertrophic cardiomyopathy. European Journal of Human Genetics, 25(7), 809–815. https://doi.org/10.1038/ejhg.2017.66.
Cella, D., Hughes, C., Peterman, A., Chang, C. H., Peshkin, B. N., Schwartz, M. D., … Lerman, C. (2002). A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health Psychol, 21(6), 564–572.
Christiaans, I., van Langen, I. M., Birnie, E., Bonsel, G. J., Wilde, A. A., & Smets, E. M. (2009). Quality of life and psychological distress in hypertrophic cardiomyopathy mutation carriers: a cross-sectional cohort study. American Journal of Medical Genetics. Part A, 149a(4), 602–612. https://doi.org/10.1002/ajmg.a.32710.
Gong, P., Fanos, J. H., Korty, L., Siskind, C. E., & Hanson-Kahn, A. K. (2016). Impact of Huntington disease gene-positive status on pre-symptomatic young adults and recommendations for genetic counselors. Journal of Genetic Counseling, 25(6), 1188–1197. https://doi.org/10.1007/s10897-016-9951-z.
Graves, K. D., Vegella, P., Poggi, E. A., Peshkin, B. N., Tong, A., Isaacs, C., … Schwartz, M. D. (2012). Long-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choice. Cancer Epidemiol Biomarkers Prev, 21(3), 445–455. doi:https://doi.org/10.1158/1055-9965.EPI-11-0991.
Hamilton, J. G., Lobel, M., & Moyer, A. (2009). Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review. Health Psychology, 28(4), 510–518. https://doi.org/10.1037/a0014778.
Hickey, K. T., Sciacca, R. R., Biviano, A. B., Whang, W., Dizon, J. M., Garan, H., & Chung, W. K. (2014). The effect of cardiac genetic testing on psychological well-being and illness perceptions. Heart & Lung, 43(2), 127–132. https://doi.org/10.1016/j.hrtlng.2014.01.006.
Holmes-Rovner, M., Kroll, J., Schmitt, N., Rovner, D. R., Breer, M. L., Rothert, M. L., … Talarczyk, G. (1996). Patient satisfaction with health care decisions: the satisfaction with decision scale. Med Decis Making, 16(1), 58–64. doi:https://doi.org/10.1177/0272989X9601600114.
Horowitz, M., Wilner, N., & Alvarez, W. (1979). Impact of event scale: a measure of subjective stress. Psychosomatic Medicine, 41(3), 209–218.
Ingles, J., Lind, J. M., Phongsavan, P., & Semsarian, C. (2008). Psychosocial impact of specialized cardiac genetic clinics for hypertrophic cardiomyopathy. Genetics in Medicine, 10(2), 117–120. https://doi.org/10.1097/GIM.0b013e3181612cc7.
Ingles, J., Yeates, L., O'Brien, L., McGaughran, J., Scuffham, P. A., Atherton, J., & Semsarian, C. (2012). Genetic testing for inherited heart diseases: longitudinal impact on health-related quality of life. Genetics in Medicine. https://doi.org/10.1038/gim.2012.47.
Lumish, H. S., Steinfeld, H., Koval, C., Russo, D., Levinson, E., Wynn, J., … Chung, W. K. (2017). Impact of panel gene testing for hereditary breast and ovarian cancer on patients. J Genet Couns. doi: https://doi.org/10.1007/s10897-017-0090-y.
O’Neill, S. C., Rini, C., Goldsmith, R. E., Valdimarsdottir, H., Cohen, L. H., & Schwartz, M. D. (2009). Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes. Psycho-Oncology, 18(10), 1088–1096. https://doi.org/10.1002/pon.1467.
Rich, T. A., Liu, M., Etzel, C. J., Bannon, S. A., Mork, M. E., Ready, K., … Litton, J. K. (2014). Comparison of attitudes regarding preimplantation genetic diagnosis among patients with hereditary cancer syndromes. Fam Cancer, 13(2), 291–299. doi:https://doi.org/10.1007/s10689-013-9685-0.
Ringwald, J., Wochnowski, C., Bosse, K., Giel, K. E., Schaffeler, N., Zipfel, S., & Teufel, M. (2016). Psychological distress, anxiety, and depression of cancer-affected BRCA1/2 mutation carriers: a systematic review. Journal of Genetic Counseling, 25(5), 880–891. https://doi.org/10.1007/s10897-016-9949-6.
Sabater-Molina, M., Perez-Sanchez, I., Hernandez Del Rincon, J. P., & Gimeno, J. R. (2017). Genetics of hypertrophic cardiomyopathy: a review of current state. Clinical Genetics. https://doi.org/10.1111/cge.13027.
SAS Institute Inc. SAS 9.4 [computer program]. (2014). Cary: SAS Institute Inc.
Watkins, H., Ashrafian, H., & Redwood, C. (2011). Inherited cardiomyopathies. The New England Journal of Medicine, 364(17), 1643–1656. https://doi.org/10.1056/NEJMra0902923.
Weiss, R. S., & Richards, T. A. (1997). A scale for predicting quality of recovery following the death of a partner. Journal of Personality and Social Psychology, 72(4), 885–891.
Zick, C. D., Mathews, C. J., Roberts, J. S., Cook-Deegan, R., Pokorski, R. J., & Green, R. C. (2005). Genetic testing for Alzheimer’s disease and its impact on insurance purchasing behavior. Health Aff (Millwood), 24(2), 483–490. https://doi.org/10.1377/hlthaff.24.2.483.
Acknowledgments
We would like to thank Mikaela Lum and Nicole Salvatore for their enrollment of the study participants. We would also like to thank the study participants.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
David T. Holland, Julia Wynn, Jimmy Duong, Priyanka Ahimaz, and Wendy K. Chung declare that they have no conflict of interest.
Human Studies and Informed Consent Statement
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinski Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.
Animal Studies
No animal studies were carried out by the authors for this article.
Comments
This manuscript was submitted solely to the Journal of Genetic Counseling and was not published elsewhere.
Electronic supplementary material
ESM 1
(DOCX 64 kb)
Rights and permissions
About this article
Cite this article
Wynn, J., Holland, D.T., Duong, J. et al. Examining the Psychosocial Impact of Genetic Testing for Cardiomyopathies. J Genet Counsel 27, 927–934 (2018). https://doi.org/10.1007/s10897-017-0186-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-017-0186-4